485 related articles for article (PubMed ID: 18349709)
1. Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: a naturalistic study.
Capone GT; Goyal P; Grados M; Smith B; Kammann H
J Dev Behav Pediatr; 2008 Apr; 29(2):106-16. PubMed ID: 18349709
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.
Troost PW; Lahuis BE; Steenhuis MP; Ketelaars CE; Buitelaar JK; van Engeland H; Scahill L; Minderaa RB; Hoekstra PJ
J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1137-44. PubMed ID: 16239862
[TBL] [Abstract][Full Text] [Related]
3. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
4. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
[TBL] [Abstract][Full Text] [Related]
5. Risperidone in children with disruptive behavior disorders and subaverage intelligence: a 1-year, open-label study of 504 patients.
Croonenberghs J; Fegert JM; Findling RL; De Smedt G; Van Dongen S;
J Am Acad Child Adolesc Psychiatry; 2005 Jan; 44(1):64-72. PubMed ID: 15608545
[TBL] [Abstract][Full Text] [Related]
6. Role of risperidone in children with autism spectrum disorder.
Chavez B; Chavez-Brown M; Rey JA
Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
[TBL] [Abstract][Full Text] [Related]
7. Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.
Akhondzadeh S; Fallah J; Mohammadi MR; Imani R; Mohammadi M; Salehi B; Ghanizadeh A; Raznahan M; Mohebbi-Rasa S; Rezazadeh SA; Forghani S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):32-6. PubMed ID: 19772883
[TBL] [Abstract][Full Text] [Related]
8. Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.
Research Units on Pediatric Psychopharmacology Autism Network
Am J Psychiatry; 2005 Jul; 162(7):1361-9. PubMed ID: 15994720
[TBL] [Abstract][Full Text] [Related]
9. Open trial of risperidone in 24 young children with pervasive developmental disorders.
Masi G; Cosenza A; Mucci M; Brovedani P
J Am Acad Child Adolesc Psychiatry; 2001 Oct; 40(10):1206-14. PubMed ID: 11589534
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of challenging behaviours in adults with autistic disorder, PDD-NOS, and intellectual disability.
Matson JL; Rivet TT
J Intellect Dev Disabil; 2008 Dec; 33(4):323-9. PubMed ID: 19039692
[TBL] [Abstract][Full Text] [Related]
11. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
Aman MG; Gharabawi GM;
J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
[TBL] [Abstract][Full Text] [Related]
12. Children with autism spectrum disorders and intellectual disability.
McCarthy J
Curr Opin Psychiatry; 2007 Sep; 20(5):472-6. PubMed ID: 17762590
[TBL] [Abstract][Full Text] [Related]
13. Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials.
Arnold LE; Vitiello B; McDougle C; Scahill L; Shah B; Gonzalez NM; Chuang S; Davies M; Hollway J; Aman MG; Cronin P; Koenig K; Kohn AE; McMahon DJ; Tierney E
J Am Acad Child Adolesc Psychiatry; 2003 Dec; 42(12):1443-50. PubMed ID: 14627879
[TBL] [Abstract][Full Text] [Related]
14. Stereotypic movement disorder: easily missed.
Freeman RD; Soltanifar A; Baer S
Dev Med Child Neurol; 2010 Aug; 52(8):733-8. PubMed ID: 20187883
[TBL] [Abstract][Full Text] [Related]
15. Effects of risperidone on aberrant behavior of persons with developmental disabilities: I. A double-blind crossover study using multiple measures.
Zarcone JR; Hellings JA; Crandall K; Reese RM; Marquis J; Fleming K; Shores R; Williams D; Schroeder SR
Am J Ment Retard; 2001 Nov; 106(6):525-38. PubMed ID: 11708938
[TBL] [Abstract][Full Text] [Related]
16. Psychometric properties of the Children's Scale of Hostility and Aggression: Reactive/Proactive (C-SHARP).
Farmer CA; Aman MG
Res Dev Disabil; 2010; 31(1):270-80. PubMed ID: 19854027
[TBL] [Abstract][Full Text] [Related]
17. Risperidone-to-methylphenidate switch reaction in children: three cases.
Sabuncuoglu O
J Psychopharmacol; 2007 Mar; 21(2):216-9. PubMed ID: 17329303
[TBL] [Abstract][Full Text] [Related]
18. An open clinical trial of risperidone monotherapy in young children with autistic disorder.
Findling RL; Maxwell K; Wiznitzer M
Psychopharmacol Bull; 1997; 33(1):155-9. PubMed ID: 9133768
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence.
Aman MG; De Smedt G; Derivan A; Lyons B; Findling RL;
Am J Psychiatry; 2002 Aug; 159(8):1337-46. PubMed ID: 12153826
[TBL] [Abstract][Full Text] [Related]
20. Behavior problems: differences among intellectually disabled adults with co-morbid autism spectrum disorders and epilepsy.
Smith KR; Matson JL
Res Dev Disabil; 2010; 31(5):1062-9. PubMed ID: 20452741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
